Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group.
J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.
Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.
Dixon BP, Greenbaum LA, Huang L, Rajan S, Ke C, Zhang Y, Li L.
Kidney Int Rep. 2023 Aug 25;8(11):2284-2293. doi: 10.1016/j.ekir.2023.08.033. eCollection 2023 Nov.
PMID:38025230
Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti-CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study.
Rovin BH, Boxhammer R, Thakur A, Ronco PM.
Kidney Int Rep. 2022 Sep;7(9):2086-2090. doi: 10.1016/j.ekir.2022.05.031. Epub 2022 Jun 10.
PMID:35702397
Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.
Waldman M, Beck LH Jr, Braun M, Wilkins K, Balow JE, Austin HA 3rd.
Kidney Int Rep. 2016 Jul;1(2):73-84. doi: 10.1016/j.ekir.2016.05.002. Epub 2016 Jun 11.
PMID:27942609
Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous Nephropathy Caused by Syphilis: A Case Report.
Honda D, Okunaga I, Omote D, Inoue H, Yamasaki K, Wakabayashi H, Suzuki M, Aizawa M, Tomita S, Ikeda JI, Asanuma K.
Am J Kidney Dis. 2024 Aug;84(2):250-254. doi: 10.1053/j.ajkd.2024.02.007. Epub 2024 Mar 22.
PMID:38522728
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
Fehmi J, Davies AJ, Antonelou M, Keddie S, Pikkupeura S, Querol L, Delmont E, Cortese A, Franciotta D, Persson S, Barratt J, Pepper R, Farinha F, Rahman A, Canetti D, Gilbertson JA, Rendell NB, Radunovic A, Minton T, Fuller G, Murphy SM, Carr AS, Reilly MR, Eftimov F, Wieske L, Teunissen CE, Roberts ISD, Ashman N, Salama AD, Rinaldi S.
PLoS One. 2023 Mar 9;18(3):e0281156. doi: 10.1371/journal.pone.0281156. eCollection 2023.
PMID:36893151
Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here?
Kronbichler A, Gauckler P, Lee KH, Shin JI, Malvezzi P, Mayer G.
Atheroscler Suppl. 2019 Dec;40:55-60. doi: 10.1016/j.atherosclerosissup.2019.08.027. Epub 2019 Aug 17.
PMID:31447217
Does cyclophosphamide still play a role in glomerular diseases?
Ponticelli C, Escoli R, Moroni G.
Autoimmun Rev. 2018 Oct;17(10):1022-1027. doi: 10.1016/j.autrev.2018.04.007. Epub 2018 Aug 11.
PMID:30107267
Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
Liu D, Yang Y, Kuang F, Qing S, Hu B, Yu X.
Int Immunopharmacol. 2019 May;70:354-361. doi: 10.1016/j.intimp.2019.03.002. Epub 2019 Mar 7.